FI955825A0 - Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksi - Google Patents
Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksiInfo
- Publication number
- FI955825A0 FI955825A0 FI955825A FI955825A FI955825A0 FI 955825 A0 FI955825 A0 FI 955825A0 FI 955825 A FI955825 A FI 955825A FI 955825 A FI955825 A FI 955825A FI 955825 A0 FI955825 A0 FI 955825A0
- Authority
- FI
- Finland
- Prior art keywords
- formula
- enantiomerically pure
- alkyl
- preparation
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4443168A DE4443168A1 (de) | 1994-12-05 | 1994-12-05 | Neues hochselektives Verfahren zur Herstellung von enantiomerenreinen phenylsubstituierten 1,4-Dihydropyridin-3,5-dicarbonsäurederivaten |
| DE4443168 | 1994-12-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI955825A0 true FI955825A0 (fi) | 1995-12-04 |
| FI955825A FI955825A (fi) | 1996-06-06 |
| FI115908B FI115908B (fi) | 2005-08-15 |
Family
ID=6534908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI955825A FI115908B (fi) | 1994-12-05 | 1995-12-04 | Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksi |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US5700948A (fi) |
| EP (2) | EP0716081B1 (fi) |
| JP (1) | JP3891500B2 (fi) |
| KR (1) | KR100396011B1 (fi) |
| CN (5) | CN1079793C (fi) |
| AT (1) | ATE322482T1 (fi) |
| AU (1) | AU702274B2 (fi) |
| CA (1) | CA2164276C (fi) |
| CZ (1) | CZ296438B6 (fi) |
| DE (2) | DE4443168A1 (fi) |
| DK (1) | DK0716081T3 (fi) |
| ES (1) | ES2262138T3 (fi) |
| FI (1) | FI115908B (fi) |
| HU (1) | HU214683B (fi) |
| IL (1) | IL116225A (fi) |
| MX (1) | MX9504954A (fi) |
| MY (1) | MY112938A (fi) |
| NO (1) | NO312832B1 (fi) |
| NZ (1) | NZ280578A (fi) |
| PL (1) | PL183604B1 (fi) |
| PT (1) | PT716081E (fi) |
| RU (1) | RU2155752C2 (fi) |
| SG (1) | SG73352A1 (fi) |
| SI (1) | SI0716081T1 (fi) |
| SK (1) | SK282428B6 (fi) |
| TW (1) | TW310324B (fi) |
| ZA (1) | ZA9510263B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102533154B1 (ko) | 2022-09-22 | 2023-05-17 | 임태형 | 안전계단 난간대 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932646A (en) * | 1971-04-10 | 1976-01-13 | Farbenfabriken Bayer Ag | Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate |
| JPS6058239B2 (ja) * | 1978-07-20 | 1985-12-19 | 山之内製薬株式会社 | 新規セフアロスポリン誘導体 |
| DE2911029C2 (de) * | 1979-03-21 | 1985-03-14 | Kombi-Lift Montage- Und Handelsgesellschaft Mbh, 5650 Solingen | Vorrichtung zum Haltern der Führungsrollen für die Lastseile eines Fassadenseilaufzuges in einem oben am Gebäude fest angeordneten Gehäuse |
| GR850872B (fi) * | 1984-04-16 | 1985-11-25 | Yamanouchi Pharma Co Ltd | |
| US4539302A (en) * | 1984-04-30 | 1985-09-03 | E. I. Du Pont De Nemours And Company | Recovery of zerovalent nickel complexes |
| DE3423105A1 (de) * | 1984-06-22 | 1986-01-02 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine |
-
1994
- 1994-12-05 DE DE4443168A patent/DE4443168A1/de not_active Withdrawn
-
1995
- 1995-11-16 MY MYPI95003487A patent/MY112938A/en unknown
- 1995-11-17 TW TW084112189A patent/TW310324B/zh active
- 1995-11-22 EP EP95118359A patent/EP0716081B1/de not_active Expired - Lifetime
- 1995-11-22 PT PT95118359T patent/PT716081E/pt unknown
- 1995-11-22 AT AT95118359T patent/ATE322482T1/de active
- 1995-11-22 ES ES95118359T patent/ES2262138T3/es not_active Expired - Lifetime
- 1995-11-22 SI SI9530725T patent/SI0716081T1/sl unknown
- 1995-11-22 DE DE59511043T patent/DE59511043D1/de not_active Expired - Lifetime
- 1995-11-22 DK DK95118359T patent/DK0716081T3/da active
- 1995-11-22 EP EP04009787A patent/EP1443043A3/de not_active Withdrawn
- 1995-11-28 US US08/563,725 patent/US5700948A/en not_active Ceased
- 1995-11-28 MX MX9504954A patent/MX9504954A/es unknown
- 1995-11-29 AU AU39150/95A patent/AU702274B2/en not_active Ceased
- 1995-11-30 PL PL95311539A patent/PL183604B1/pl not_active IP Right Cessation
- 1995-12-01 NO NO19954885A patent/NO312832B1/no not_active IP Right Cessation
- 1995-12-01 JP JP33570795A patent/JP3891500B2/ja not_active Expired - Fee Related
- 1995-12-01 CA CA002164276A patent/CA2164276C/en not_active Expired - Fee Related
- 1995-12-01 NZ NZ280578A patent/NZ280578A/en not_active IP Right Cessation
- 1995-12-01 HU HU9503438A patent/HU214683B/hu not_active IP Right Cessation
- 1995-12-01 IL IL11622595A patent/IL116225A/xx not_active IP Right Cessation
- 1995-12-04 ZA ZA9510263A patent/ZA9510263B/xx unknown
- 1995-12-04 SK SK1526-95A patent/SK282428B6/sk not_active IP Right Cessation
- 1995-12-04 CZ CZ0320595A patent/CZ296438B6/cs not_active IP Right Cessation
- 1995-12-04 KR KR1019950046341A patent/KR100396011B1/ko not_active IP Right Cessation
- 1995-12-04 FI FI955825A patent/FI115908B/fi not_active IP Right Cessation
- 1995-12-04 SG SG1995002018A patent/SG73352A1/en unknown
- 1995-12-05 RU RU95121073/04A patent/RU2155752C2/ru not_active IP Right Cessation
- 1995-12-05 CN CN95119057A patent/CN1079793C/zh not_active Expired - Fee Related
-
1997
- 1997-07-16 US US08/896,275 patent/US5849924A/en not_active Expired - Lifetime
-
1998
- 1998-09-21 US US09/158,428 patent/US5910593A/en not_active Expired - Lifetime
-
1999
- 1999-03-25 US US09/276,220 patent/USRE36607E/en not_active Expired - Lifetime
- 1999-12-30 CN CN991275276A patent/CN1216054C/zh not_active Expired - Fee Related
- 1999-12-30 CN CN99127530A patent/CN1094926C/zh not_active Expired - Fee Related
- 1999-12-30 CN CN99127528A patent/CN1094486C/zh not_active Expired - Fee Related
- 1999-12-30 CN CN99127529A patent/CN1105102C/zh not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1036794A4 (en) | 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES | |
| YU28500A (sh) | Postupak za dobivanje 1,4-dihidropiridina i jedinjenja koja se primenjuju u tom postupku | |
| FI955825A (fi) | Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksi | |
| HUP9801442A2 (hu) | Fenil-ecetsav-származékok, eljárás és intermedierek előállításukhoz, valamint inszekticidként, akaricidként, nematocidként és fungicidként való alkalmazásuk | |
| KR960022464A (ko) | 5-아실-1,4-디히드로피리딘류의 용도 | |
| WO2000018722A3 (es) | Nuevos derivados de la 6-(4-fenilbutoxi)hexilamina y procedimiento para la obtencion de salmeterol | |
| DK0665221T3 (da) | Vitamin D derivat og fremgangsmåde til fremstilling af dette | |
| AU4029495A (en) | Use of 1,2-bridged 1,4-dihydropyridines as medicaments | |
| DE69830850D1 (de) | Aminderivate und verfahren zu ihrer herstellung | |
| DK468385A (da) | Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester | |
| DE69031730D1 (de) | Neues Antibiotikum, Deoxymulündocandin, Verfahren zu seiner Produktion und Verwendung als Medikament | |
| FR2692518B3 (fr) | Procédé de fabrication d'un objet, notamment d'un carreau en terre cuite décoratif, et objet obtenu par ce procédé. | |
| GR3022713T3 (en) | Process for the vacylation of threonine derivatives and their use in the preparation of 1,4-dihydropyridines. | |
| DK549789D0 (da) | Fremgangsmaade til fremstilling af optisk aktive acyloxyazetidinoner | |
| HU9702339D0 (en) | Process for producing intermediates of phenyl-substituted 1,4-dihydro-pyridine-3,5-dicarboxylic acid derivatives and the intermediate compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 115908 Country of ref document: FI |
|
| PC | Transfer of assignment of patent |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
|
| PC | Transfer of assignment of patent |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
|
| MM | Patent lapsed |